Is a Beat in Store for BioNTech (BNTX) This Earnings Season? Posted byZacks Equity Research November 8, 2021 Leave a comment on Is a Beat in Store for BioNTech (BNTX) This Earnings Season? On BioNTech’s (BNTX) third-quarter earnings call, investors’ focus is expected to be on the sales performance of Comirnaty, its COVID-19 vaccine developed in partnership with Pfizer.